Story perspectives

Analysts Boost Ratings and Targets for Key Canadian Stocks

6/17/2025

33 5

Summary

Story summary

Canaccord's Yuri Lynk maintains a "buy" rating for Mattr Corp. (MATR-T) with a C$16 target, highlighting strong growth potential.
Eupraxia Pharmaceuticals (EPRX-T) earns a "speculative buy" rating from Canaccord, targeting C$9 for its new eosinophilic esophagitis treatment.
Scotiabank raises price targets for Canadian miners, predicting a tighter copper market amid economic uncertainties.
DA Davidson increases Shopify Inc.'s (SHOP-Q) target to US$125, citing improved merchant growth and e-commerce resilience.
Citigroup lowers Ivanhoe Mines Ltd.'s (IVN-T) target to C$14 but keeps a "buy" rating, adding it to the "upside catalyst watch."

1 of 1

Story summary

Canaccord's Yuri Lynk maintains a "buy" rating for Mattr Corp. (MATR-T) with a C$16 target, highlighting strong growth potential.
Eupraxia Pharmaceuticals (EPRX-T) earns a "speculative buy" rating from Canaccord, targeting C$9 for its new eosinophilic esophagitis treatment.
Scotiabank raises price targets for Canadian miners, predicting a tighter copper market amid economic uncertainties.
DA Davidson increases Shopify Inc.'s (SHOP-Q) target to US$125, citing improved merchant growth and e-commerce resilience.
Citigroup lowers Ivanhoe Mines Ltd.'s (IVN-T) target to C$14 but keeps a "buy" rating, adding it to the "upside catalyst watch."